Amy Comstock Rick is a principal based in Washington, D.C. Amy leads the Medicines Development Modernization Initiative and advises on federal health care policy, FDA, NIH, drug development and research educational convenings, and patient engagement initiatives. Amy has over 30 years of experience leading organizations, executing strategy, transforming organizational culture, building consensus, and advocating policies across constituencies. From 2014 – 2022 she served as the President and Chief Executive Officer of the Food and Drug Law Institute (FDLI).  FDLI is a multi-stakeholder, educational non-profit organization dedicated to providing topical and timely conferences, courses, and publications to inform public policy, law, and regulation in all aspects of food and drug law.  Prior to joining FDLI, Amy was the Chief Executive Officer of the Parkinson’s Action Network (PAN) from 2003-2014.  PAN was a Washington D.C.-based national nonprofit focused on educating the public and government leaders on better policies for research and therapy development and an improved quality of life for people living with Parkinson’s disease.  Amy serves on the Board of Directors of Research!America and One Mind. Amy has also served as the President of the Coalition for the Advancement of Medical Research, on the NIH Institute for Neurological Disorders and Stroke’s Advisory Council, and on the Boards of Directors of the National Health Council and the American Brain Coalition. Before joining PAN, she was the Senate-confirmed Director of the U.S. Office of Government Ethics from 2000-2003 and the Associate Counsel to the President in the White House Counsel’s Office from 1998-2000.  Ms. Rick began her federal service as a career attorney at the U.S. Department of Education, Office of the General Counsel. Amy received a Bachelor of Arts degree from Bard College and a Juris Doctor degree from the University of Michigan.